ON TRACK INNOVATIONS LTD.
(Registrant)
|
|||
By:
|
/s/ Oded Bashan
|
||
Oded Bashan
|
|||
Chief Executive Officer and
Chairman
|
![]() |
Press Release
|
·
|
Total revenues increased by 9% for the three months ended September 30, 2012 to $9.3 million from $8.5 million for the three months ended September 2011. Total revenues for the nine months ended September 30, 2012 decreased by 16% to $29.7 million from $35.2 million for the first nine months of 2011
|
·
|
Gross margin for the third quarter of 2012 was 55% compared to 45% for the same period last year. Gross margin for the nine months ended September 30, 2012 was 52%, compared to 49% for the same period in 2011
|
·
|
Operating expenses for Q3 2012 decreased by 7% to $7.0 million from $7.5 million for same period last year. Operating expenses for the first nine months of 2012 decreased by 4% to $22.2 million from $23.1 million for the first nine months of 2011
|
·
|
Net loss attributable to shareholders for Q3 2012 decreased by 48% to $1.9 million from $3.6 million last year. Net loss attributable to shareholders for the first nine months of 2012 $7.6 million, from $5.9 million last year
|
·
|
Adjusted EBITDA loss for Q3 2012 of $1.0 million from $2.8 million last year. Adjusted EBITDA loss for the first nine months of 2012 was $4.7 million, from $2.8 million last year
|
·
|
Cash, cash equivalents and short-term investments of $20 million as of September 30, 2012
|
·
|
Order received for 17,000 NFC and Contactless Payment Readers:
|
|
—
|
To be deployed in Europe. Follows order of 30,000 readers in the first quarter of 2012
|
·
|
OTI and Wright Express sign a strategic cooperation agreement:
|
|
—
|
Five year agreement with Wright Express appoints OTI as the exclusive reseller in South Africa of Wright Express’ Quantum+ solution
|
·
|
The City of Dover, NH Selects OTI’s EasyPark™ System
|
|
—
|
Dover is the first city in the Northeast of the U.S. to select EasyPark for public parking needs
|
·
|
Order received for $2 Million in orders for NFC and contactless payment readers for use in the U.S.
|
·
|
OTI introduces COPNI Wave - the first plug-in solution to turn mobile phones into NFC based mobile payment devices
|
September 30
|
December 31
|
|||||||
2012
|
2011
|
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$ | 12,497 | $ | 12,517 | ||||
Short-term investments
|
7,453 | 15,952 | ||||||
Trade receivables (net of allowance for doubtful
|
||||||||
accounts of $229 and $233 as of September 30, 2012
|
||||||||
and December 31, 2011, respectively)
|
7,448 | 11,328 | ||||||
Other receivables and prepaid expenses
|
2,375 | 1,947 | ||||||
Inventories
|
7,963 | 8,196 | ||||||
Total current assets
|
37,736 | 49,940 | ||||||
Long term restricted deposit
|
3,256 | - | ||||||
Property, plant and equipment, net
|
12,951 | 13,227 | ||||||
Intangible assets, net
|
3,438 | 1,886 | ||||||
Goodwill
|
485 | 485 | ||||||
Total Assets
|
$ | 57,866 | $ | 65,538 |
September 30
|
December 31
|
|||||||
2012
|
2011
|
|||||||
(Unaudited)
|
(Unaudited)
|
|||||||
Liabilities and Equity
|
||||||||
Current Liabilities
|
||||||||
Short-term bank credit and current maturities
|
||||||||
of long-term bank loans
|
$ | 7,833 | $ | 6,793 | ||||
Trade payables
|
8,040 | 8,441 | ||||||
Other current liabilities
|
5,055 | 5,730 | ||||||
Total current liabilities
|
20,928 | 20,964 | ||||||
Long-Term Liabilities
|
||||||||
Long-term loans, net of current maturities
|
2,318 | 4,026 | ||||||
Employee benefits
|
5,639 | 4,064 | ||||||
Royalty liability to the office of the Chief Scientist, net of current maturities
|
3,948 | 3,811 | ||||||
Deferred tax liability
|
56 | 65 | ||||||
Total long-term liabilities
|
11,961 | 11,966 | ||||||
Total Liabilities
|
32,889 | 32,930 | ||||||
Liabilities related to discontinued operation
|
- | 150 | ||||||
Commitments and Contingencies
|
||||||||
Equity
|
||||||||
Shareholders' Equity
|
||||||||
Ordinary shares of NIS 0.1 par value: Authorized –
|
||||||||
50,000,000 shares as of September 30, 2012 and
|
||||||||
December 31, 2011; issued: 32,693,261 and 32,313,761
|
||||||||
shares as of September 30, 2012 and December 31, 2011,
|
||||||||
respectively; outstanding: 31,514,562 and 31,135,062 shares
|
||||||||
as of September 30, 2012 and December 31, 2011, respectively
|
817 | 808 | ||||||
Additional paid-in capital
|
210,869 | 209,693 | ||||||
Treasury shares at cost –1,178,699 shares as of September 30, 2012
|
||||||||
and December 31, 2011.
|
(2,000 | ) | (2,000 | ) | ||||
Accumulated other comprehensive loss
|
(16 | ) | (174 | ) | ||||
Accumulated deficit
|
(184,347 | ) | (175,582 | ) | ||||
Total Shareholder’s equity
|
25,323 | 32,745 | ||||||
Non-controlling interest
|
(346 | ) | (287 | ) | ||||
Total Equity
|
24,977 | 32,458 | ||||||
Total Liabilities and Equity
|
$ | 57,866 | $ | 65,538 |
Nine months ended September 30
|
Three months ended September 30
|
|||||||||||||||
2012
|
2011
|
2012
|
2011
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||||||
Revenues
|
||||||||||||||||
Sales
|
$ | 26,002 | $ | 31,241 | $ | 8,137 | $ | 7,243 | ||||||||
Licensing and transaction fees
|
3,673 | 3,972 | 1,198 | 1,290 | ||||||||||||
Total revenues
|
29,675 | 35,213 | 9,335 | 8,533 | ||||||||||||
Cost of revenues
|
||||||||||||||||
Cost of sales
|
14,298 | 17,919 | 4,168 | 4,668 | ||||||||||||
Total cost of revenues
|
14,298 | 17,919 | 4,168 | 4,668 | ||||||||||||
Gross profit
|
15,377 | 17,294 | 5,167 | 3,865 | ||||||||||||
Operating expenses
|
||||||||||||||||
Research and development
|
5,063 | 5,736 | 1,704 | 1,889 | ||||||||||||
Selling and marketing
|
10,211 | 9,974 | 3,322 | 3,190 | ||||||||||||
General and administrative
|
6,728 | 6,960 | 1,893 | 2,332 | ||||||||||||
Amortization of intangible assets
|
159 | 410 | 57 | 126 | ||||||||||||
Total operating expenses
|
22,161 | 23,080 | 6,976 | 7,537 | ||||||||||||
Operating loss
|
(6,784 | ) | (5,786 | ) | (1,809 | ) | (3,672 | ) | ||||||||
Financial income (expenses), net
|
(834 | ) | (40 | ) | (124 | ) | 102 | |||||||||
Loss before taxes on income
|
(7,618 | ) | (5,826 | ) | (1,933 | ) | (3,570 | ) | ||||||||
Taxes on income
|
(69 | ) | (142 | ) | 22 | (58 | ) | |||||||||
Net loss
|
(7,687 | ) | (5,968 | ) | (1,911 | ) | (3,628 | ) | ||||||||
Net loss (income) attributable to noncontrolling interest
|
58 | 60 | 22 | (5 | ) | |||||||||||
Net loss attributable to shareholders
|
$ | (7,629 | ) | $ | (5,908 | ) | $ | (1,889 | ) | $ | (3,633 | ) |
Basic and diluted net loss attributable to shareholders per ordinary share
|
$ | (0.24 | ) | $ | (0.19 | ) | $ | (0.06 | ) | $ | (0.11 | ) | ||||
Weighted average number of ordinary shares used in
|
||||||||||||||||
computing basic and diluted net loss per ordinary share
|
32,120,021 | 31,349,133 | 32,221,618 | 32,396,384 |
Nine months ended September 30
|
Three months ended September 30
|
|||||||||||||||
2012
|
2011
|
2012
|
2011
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
(Unaudited)
|
|||||||||||||
IFRS Net Loss
|
$ | (7,687 | ) | $ | (5,968 | ) | $ | (1,911 | ) | $ | (3,628 | ) | ||||
|
||||||||||||||||
Financial expenses (income), net
|
834 | 40 | 124 | (102 | ) | |||||||||||
Depreciation
|
1,049 | 1,193 | 352 | 398 | ||||||||||||
Taxes on income
|
69 | 142 | (22 | ) | 58 | |||||||||||
Amortization expenses
|
159 | 410 | 57 | 126 | ||||||||||||
TOTAL EBITDA
|
$ | (5,576 | ) | $ | (4,183 | ) | $ | (1,400 | ) | $ | (3,148 | ) | ||||
Stock based compensation
|
$ | 909 | $ | 1,432 | $ | 356 | $ | 354 | ||||||||
TOTAL ADJUSTED EBITDA
|
$ | (4,667 | ) | $ | (2,751 | ) | $ | (1,044 | ) | $ | (2,794 | ) |
Nine months ended September 30 | ||||||||
2012 |
2011
|
|||||||
(Unaudited) |
(Unaudited)
|
|||||||
Cash flows from operating activities
|
||||||||
Net loss
|
$ | (7,687 | ) | $ | (5,968 | ) | ||
Adjustments required to reconcile net loss to
|
||||||||
net cash used in operating activities:
|
||||||||
Stock-based compensation related to options and shares issued
|
||||||||
to employees and others
|
909 | 1,432 | ||||||
Loss on sale of property and equipment
|
- | 24 | ||||||
Amortization of intangible assets
|
159 | 410 | ||||||
Income taxes
|
9 | 12 | ||||||
Finance expenses (income)
|
508 | (162 | ) | |||||
Depreciation
|
1,049 | 1,193 | ||||||
(5,053 | ) | (3,059 | ) | |||||
Increase in employees benefits
|
431 | 99 | ||||||
Decrease in deferred tax liability
|
(9 | ) | (16 | ) | ||||
Linkage differences on receivable from sale of operation
|
- | (102 | ) | |||||
Decrease (increase) in trade receivables, net
|
3,923 | (949 | ) | |||||
Increase in other receivables and prepaid expenses
|
(412 | ) | (890 | ) | ||||
Decrease (increase) in inventories
|
257 | (625 | ) | |||||
Increase (decrease) in trade payables
|
(618 | ) | 1,621 | |||||
Decrease in other current liabilities
|
(399 | ) | (3,208 | ) | ||||
(1,880 | ) | (7,129 | ) | |||||
Income taxes paid
|
(9 | ) | (12 | ) | ||||
Net cash used in continuing operating activities
|
(1,889 | ) | (7,141 | ) | ||||
Net cash used in discontinued operating activities
|
(150 | ) | (231 | ) | ||||
Net cash used in operating activities
|
(2,039 | ) | (7,372 | ) | ||||
Cash flows from investing activities
|
||||||||
Purchase of property and equipment
|
(630 | ) | (1,065 | ) | ||||
Purchase of short term investments and long term restricted deposit
|
(8,066 | ) | (5,042 | ) | ||||
Acquisitions of business operations
|
(100 | ) | (400 | ) | ||||
Increase in intangible assets
|
(1,338 | ) | (856 | ) | ||||
Proceeds from maturity and sale of short term investments
|
13,184 | 5,541 | ||||||
Interest received
|
222 | 193 | ||||||
Proceeds from sale of property and equipment
|
- | 93 | ||||||
Net cash provided by (used in) continuing investing activities
|
3,272 | (1,536 | ) | |||||
Net cash provided by discontinued investing activities
|
- | 1,256 | ||||||
Net cash provided by (used in) investing activities
|
3,272 | (280 | ) | |||||
Cash flows from financing activities
|
||||||||
Increase (decrease) in short-term bank credit, net
|
1,824 | (2,070 | ) | |||||
Proceeds from long-term bank loans
|
290 | 2,638 | ||||||
Repayment of long-term bank loans
|
(2,850 | ) | (1,517 | ) | ||||
Proceeds from issuance of shares, net of issuance expenses
|
- | 16,619 | ||||||
Interest paid
|
(331 | ) | (351 | ) | ||||
Payments to acquire treasury shares
|
- | (182 | ) | |||||
Decrease in royalty liability to the office of the chief scientist
|
(371 | ) | (251 | ) | ||||
Proceeds from exercise of options and warrants, net
|
9 | 199 | ||||||
Net cash provided by (used in) continuing financing activities
|
(1,429 | ) | 15,085 | |||||
Effect of exchange rate changes on cash
|
176 | (152 | ) | |||||
Increase (decrease) in cash and cash equivalents
|
(20 | ) | 7,281 | |||||
Cash and cash equivalents at the beginning of the period
|
12,517 | 15,409 | ||||||
Cash and cash equivalents at the end of the period
|
$ | 12,497 | $ | 22,690 |
1.
|
Business combinations exemption
|
2.
|
Share-based payment transactions
|
a.
|
Adjustments to the consolidated statements of financial position as of December 31, 2011.
|
|
b.
|
Adjustments to the consolidated statements of operations for the nine months ended September 30, 2011.
|
|
c.
|
The provision of explanations with respect to the above adjustments.
|
Year ended December 31, 2011
|
||||||||||||||||
Note
|
US GAAP
|
Effect of transition to IFRS
|
IFRS
|
|||||||||||||
(Audited)*
|
(Unaudited)
|
|||||||||||||||
Assets
|
||||||||||||||||
Current assets
|
||||||||||||||||
Cash and cash equivalents
|
$ | 12,517 | $ | - | $ | 12,517 | ||||||||||
Short-term investments
|
15,952 | - | 15,952 | |||||||||||||
Trade receivables
|
11,328 | - | 11,328 | |||||||||||||
Other receivables and prepaid expenses
|
1,947 | - | 1,947 | |||||||||||||
Inventories
|
8,196 | - | 8,196 | |||||||||||||
Total current assets
|
49,940 | - | 49,940 | |||||||||||||
Severance pay deposits fund
|
A | 1,473 | (1,473 | ) | - | |||||||||||
Property, plant and equipment, net
|
13,227 | - | 13,227 | |||||||||||||
Intangible assets, net
|
B | 609 | 1,277 | 1,886 | ||||||||||||
Goodwill
|
485 | - | 485 | |||||||||||||
Total Assets
|
$ | 65,734 | $ | (196 | ) | $ | 65,538 |
Year ended December 31, 2011
|
||||||||||||||||
Note
|
US GAAP
|
Effect of transition to IFRS
|
IFRS
|
|||||||||||||
(Audited)*
|
(Unaudited)
|
|||||||||||||||
Liabilities and Equity
|
||||||||||||||||
Current Liabilities
|
||||||||||||||||
Short-term bank credit and current maturities
|
|
|||||||||||||||
of long-term bank loans
|
$ | 6,793 | $ | - | $ | 6,793 | ||||||||||
Trade payables
|
8,441 | - | 8,441 | |||||||||||||
Other current liabilities
|
E,F | 5,315 | 415 | 5,730 | ||||||||||||
Total current liabilities
|
20,549 | 415 | 20,964 | |||||||||||||
Long-Term Liabilities
|
||||||||||||||||
Long-term bank loans, net of current maturities
|
4,026 | - | 4,026 | |||||||||||||
Accrued severance pay / Employee benefits
|
A | 4,502 | (438 | ) | 4,064 | |||||||||||
Royalty liability to the office of the Chief
Scientist, net of current maturities
|
E | - | 3,811 | 3,811 | ||||||||||||
Deferred tax liability
|
65 | - | 65 | |||||||||||||
Total long-term liabilities
|
8,593 | 3,373 | 11,966 | |||||||||||||
Total Liabilities
|
29,142 | 3,788 | 32,930 | |||||||||||||
Liabilities related to discontinued operation
|
150 | - | 150 | |||||||||||||
Equity
|
||||||||||||||||
Shareholder’s equity
|
A,B,E,F | 36,729 | (3,984 | ) | 32,745 | |||||||||||
Non-controlling interest
|
(287 | ) | (287 | ) | ||||||||||||
Total Equity
|
36,442 | (3,984 | ) | 32,458 | ||||||||||||
Total Liabilities and Equity
|
$ | 65,734 | $ | (196 | ) | $ | 65,538 | |||||||||
Nine Months Ended September 30, 2011
|
||||||||||||||||
Note
|
US GAAP
|
Effect of transition to IFRS
|
IFRS
|
|||||||||||||
(Unaudited)
|
(Unaudited)
|
|||||||||||||||
Revenues
|
||||||||||||||||
Sales
|
$ | 31,241 | $ | - | $ | 31,241 | ||||||||||
Licensing and transaction fees
|
3,972 | - | 3,972 | |||||||||||||
Total revenues
|
35,213 | - | 35,213 | |||||||||||||
Cost of revenues
|
||||||||||||||||
Cost of sales
|
A,C | 18,067 | (148 | ) | 17,919 | |||||||||||
Total cost of revenues
|
18,067 | (148 | ) | 17,919 | ||||||||||||
Gross profit
|
17,146 | 148 | 17,294 | |||||||||||||
Operating expenses
|
||||||||||||||||
Research and development
|
A,B,C | 6,705 | (969 | ) | 5,736 | |||||||||||
Selling and marketing
|
A,C | 10,110 | (136 | ) | 9,974 | |||||||||||
General and administrative
|
A,C | 6,960 | - | 6,960 | ||||||||||||
Amortization of intangible assets
|
410 | - | 410 | |||||||||||||
Total operating expenses
|
24,185 | (1,105 | ) | 23,080 | ||||||||||||
Operating loss
|
(7,039 | ) | 1,253 | (5,786 | ) | |||||||||||
Financial expenses, net
|
A,D,E,F | (269 | ) | 229 | (40 | ) | ||||||||||
Loss before taxes on income
|
(7,308 | ) | 1,482 | (5,826 | ) | |||||||||||
Taxes on income
|
(142 | ) | - | (142 | ) | |||||||||||
Net loss
|
(7,450 | ) | 1,482 | (5,968 | ) | |||||||||||
Net loss attributable to non-controlling interest
|
60 | - | 60 | |||||||||||||
Net loss attributable to shareholders
|
$ | (7,390 | ) | $ | 1,482 | $ | (5,908 | ) |
A.
|
Employee benefits
|
B.
|
Intangible assets
|
C.
|
Share-based payment transaction
|
D.
|
Short-term investments
|
E.
|
Royalty liability to the Office of the Chief Scientist
|
F.
|
Obligation to issue non-fixed amount of shares to a seller in a business combination transaction
|